A Unified Vision for Healthcare The goal of universal access to essential medicines is driving international regulatory harmonization. The Rituximab Market Global Outlook is increasingly optimistic as organizations like the WHO pre-qualify biosimilars for use in developing nations. This global push ensures that the technological benefits of monoclonal antibodies are not restricted to...